The launch underscores a broader ongoing shift in logistics automation from isolated task-based systems toward coordinated, AI-managed operations spanning the full warehouse workflow.
However, fragmented follow-up systems and limited post-discharge tracking have long been cited as weaknesses in standard care pathways.
The launch comes weeks after Qwen’s earlier G1 model captured more than 70% of China’s online AI glasses segment in its first week on sale, market data show.
WeDoctor, a unicorn headquartered in Hangzhou, has been building out its own AI-driven healthcare network through partnerships with local governments.
The technology has long been dominated by suppliers such as Infineon Technologies and onsemi, with local suppliers historically accounting for less than 20% of the market.
The Hangzhou-based company’s public tranche was oversubscribed about 1,071 times, with total margin financing and subscriptions reaching HK$131.2 billion ($16.75 billion).
The collaboration spans the full AI stack, including data processing, model training, inference acceleration and application deployment.
Cannabinoid compounds are known to be effective in treating conditions such as chronic pain, anxiety and epilepsy, but their clinical use has been constrained by risks of addiction and other side effects.
The results come as Geely marks its 40th anniversary and advances its long-term “One Geely” strategy outlined in the 2024 “Taizhou Declaration.”
The rollout addresses a common limitation in existing AI assistants, which often output tables in text form or require pre-set templates, leaving users to manually transfer results into spreadsheet software.
